These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 8478848

  • 1. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus.
    Pérez-Vázquez ME, Villa AR, Drenkard C, Cabiedes J, Alarcón-Segovia D.
    J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848
    [Abstract] [Full Text] [Related]

  • 2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 4. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J, Cabral AR, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 6. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 7. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D, Mestanza M, Cabiedes J, Cabral AR.
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [Abstract] [Full Text] [Related]

  • 8. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS.
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [Abstract] [Full Text] [Related]

  • 9. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E, Glidden DV, Elder ME.
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [Abstract] [Full Text] [Related]

  • 10. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L, Markovic O, Marisavljevic D, Elezovic I, Ilijevski N, Stanisavljevic N.
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [Abstract] [Full Text] [Related]

  • 11. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
    Molta C, Meyer O, Dosquet C, Montes de Oca M, Babron MC, Danon F, Kaplan C, Clémenceau S, Castellano F, Levy M.
    Pediatrics; 1993 Dec; 92(6):849-53. PubMed ID: 8233748
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 13. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [Abstract] [Full Text] [Related]

  • 15. Clinical manifestations of the antiphospholipid syndrome.
    Alarcón-Segovia D.
    J Rheumatol; 1992 Nov; 19(11):1778-81. PubMed ID: 1491400
    [Abstract] [Full Text] [Related]

  • 16. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus.
    Asherson RA, Lioté F, Page B, Meyer O, Buchanan N, Khamashta MA, Jungers P, Hughes GR.
    J Rheumatol; 1993 Feb; 20(2):284-8. PubMed ID: 8474066
    [Abstract] [Full Text] [Related]

  • 17. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M.
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [Abstract] [Full Text] [Related]

  • 18. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 19. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.
    Drenkard C, Villa AR, Alarcón-Segovia D, Pérez-Vázquez ME.
    J Rheumatol; 1994 Jun; 21(6):1067-72. PubMed ID: 7932417
    [Abstract] [Full Text] [Related]

  • 20. [Corticosteroids in the treatment of secondary antiphospholipid syndrome].
    Reshetniak TM, Aleksandrova EN, Alekberova ZS, Mach ES, Nasonov EL.
    Klin Med (Mosk); 2002 Jun; 80(6):17-21. PubMed ID: 12138794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.